Evidence map›Paper›PMID 42579261›Full record

ArticleJournal of fluorescence2026

A Dual-Emission Probe Based on Silicon Nanoparticles and Rhodamine B for Ratiometric Fluorescence/Colorimetric Dual-Mode Detection of Methyl Parathion.

Mengxin Li, Congjie Pan, Liu Wang, Qiujuan Ma

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of fluorescence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mengxin LiSchool of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, 450046, China.
Congjie PanSchool of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, 450046, China. pancongjie@hactcm.edu.cn.
Liu WangSchool of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, 450046, China.
Qiujuan MaSchool of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, 450046, China. maqiujuan104@126.com.

Funding

Key Specialized Research and Development Breakthrough of Henan Province 252102321126
6 · The paper itself

Abstract

In this study, blue fluorescent silicon nanoparticles (SiNPs) were synthesized via a hydrothermal method by using 3-(aminopropyl)triethoxysilane (APTES) and L-cysteine as precursors. Then SiNPs were combined with rhodamine B (RhB) to form an enzyme-free ratiometric fluorescence probe. Under 383 nm excitation, the SiNPs@RhB probe emitted two peaks at 457 nm and 565 nm, which could be applied to detect methyl parathion in a ratiometric fluorescence/colorimetric dual-mode detection system. In an alkaline environment, methyl parathion can be hydrolyzed and lead to its absorption peak significantly shifted to 400 nm. In the ratiometric fluorescence manner, the fluorescence of the SiNPs@RhB probe at 457 nm and 565 nm was weakened in different degrees by internal filter effect (IFE) and static quenching effect (SQE). A good linear relationship could be obtained in the range of 0.1-100 µmol/L with a detection limit of 0.03 µmol/L. Furthermore, as the concentration of methyl parathion increased, the absorbance of the SiNPs@RhB probe at 400 nm also gradually increased, accompanying a change in solution color from pink to orange. Therefore, a colorimetric method was also constructed for methyl parathion detection with linear range of 0.1-200 µmol/L and a detection limit of 0.03 µmol/L. The proposed methods could be used to detect methyl parathion in real samples of lake water, soil, gongju, and sanqi powder with satisfactory recoveries.

Indexed as

Colorimetric detectionDual-emission fluorescence probeMethyl parathionRatiometric fluorescence detectionSilicon nanoparticles

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.